ArticleHereditas2026

Analysis of the biological mechanism of Gurigumu-13 in the treatment of non-alcoholic fatty liver disease based on network pharmacology.

Jie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.